Panbela Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$26.20 | -$26.20 | -$26.20 |
| Q2 2024 | 1 | -$24.00 | -$24.00 | -$24.00 |
| Q3 2024 | 1 | -$22.00 | -$22.00 | -$22.00 |
Panbela Therapeutics, Inc. Earnings Date And Information
Panbela Therapeutics, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-1.47 earnings per share for the quarter, topping analysts' consensus estimates of $-2.07 by $0.6. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Panbela Therapeutics, Inc. has generated $-232,430 earnings per share over the last year ($-232429.55 diluted earnings per share) and currently has a price-to-earnings ratio of -0.06. Panbela Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Panbela Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$1.48 | $0 | $0 | ||
| 08/13/2024 | Q2 2024 | -$2.07 | -$1.47 | 0.6 | $0 | $0 |
| 05/15/2024 | Q1 2024 | -$1.23 | -$2.28 | -1.05 | $0 | |
| 03/26/2024 | Q4 2023 | -$24.34 | -$0.03 | 24.31 | $0 | |
| 11/09/2023 | Q3 2023 | -$41.20 | -$53.74 | -12.54 | $0 | |
| 08/10/2023 | Q2 2023 | -$94.20 | -$159.09 | -64.89 | $0 | |
| 05/04/2023 | Q1 2023 | -$294.29 | -$46.64 | 247.65 | $0 | |
| 03/16/2023 | Q4 2022 | $3.70 | -$3,409.76 | -3413.46 | $-1,638,000 | |
| 11/10/2022 | Q3 2022 | -$5,525.53 | -$5,083.91 | 441.62 | $0 | |
| 08/15/2022 | Q2 2022 | -$5,285.29 | -$36,243.78 | -30958.49 | $0 | |
| 05/12/2022 | Q1 2022 | -$6,246.25 | -$6,543.64 | -297.39 | $0 | |
| 03/24/2022 | Q4 2021 | -$4,564.56 | -$6,321.06 | -1756.5 | $-1,215,000 | |
| 11/10/2021 | Q3 2021 | -$6,486.49 | -$3,869.56 | 2616.93 | $0 | |
| 08/11/2021 | Q2 2021 | -$5,525.53 | -$5,198.06 | 327.47 | $0 | |
| 05/12/2021 | Q1 2021 | -$4.40 | -$5,478.39 | -5473.99 | $0 | |
| 03/25/2021 | Q4 2020 | -$6.40 | -$109.43 | -103.03 | $1.30 M | |
| 11/12/2020 | Q3 2020 | -$4.80 | -$254.22 | -249.42 | $0 | |
| 08/11/2020 | Q2 2020 | -$74.69 | $0 | |||
| 05/12/2020 | Q1 2020 | -$325.37 | $0 | |||
| 03/24/2020 | Q4 2019 | -$176.83 | $-2,392,000 |
Panbela Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Panbela Therapeutics, Inc.'s earnings date?
Panbela Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
Did Panbela Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Panbela Therapeutics, Inc. (:PBLA) reported $-1.47 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.07 by $0.6.
-
How can I listen to Panbela Therapeutics, Inc.'s earnings conference call?
The conference call for Panbela Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Panbela Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Panbela Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Panbela Therapeutics, Inc. generate each year?
Panbela Therapeutics, Inc. (:PBLA) has a recorded net income of $0. Panbela Therapeutics, Inc. has generated $-232429.55 earnings per share over the last four quarters.
-
What is Panbela Therapeutics, Inc.'s price-to-earnings ratio?
Panbela Therapeutics, Inc. (:PBLA) has a price-to-earnings ratio of -0.06 and price/earnings-to-growth ratio is -0.
